Switzerland to host sixth GESDA Anticipation Summit in Geneva in October 2026
The Geneva Science and Diplomacy Anticipator will convene over 1,000 scientists, diplomats, policymakers and business leaders to discuss emerging technologies including AI, neurotechnologies and quantum biology.
Geneva will host the sixth summit of the Geneva Science and Diplomacy Anticipator (GESDA) on October 14-15, 2026, bringing together over 1,000 representatives from science, diplomacy, politics, private sector and philanthropy. The summit’s purpose is to identify scientific and technological breakthroughs on the horizon and promote international dialogue on their implications for society.
The event sits at an unusual intersection. Most technology conferences are industry affairs; most diplomatic gatherings focus on established policy domains. GESDA’s premise is that science diplomacy needs a dedicated forum precisely because the technologies emerging now — artificial intelligence, neurotechnologies, quantum biology — will reshape the terrain before traditional regulatory frameworks can adapt. The summit format reflects that: scientists present work that hasn’t yet reached the market, while diplomats and policymakers discuss governance structures that don’t yet exist.
The 2026 agenda will focus on several specific domains. According to GESDA, these include AI, neurotechnologies, quantum biology and what it terms “the geopolitics of science” — the question of how scientific collaboration itself becomes a terrain of international competition. The summit convenes scientists, diplomats, policymakers, innovators and citizens to explore how cutting-edge advancements might address what the organization describes as humanity’s most pressing challenges.
The “anticipation” framing matters here. GESDA was established in 2019 with funding from the Swiss government and operates as an independent foundation, not a UN body or academic conference series. Its model involves scanning scientific literature and research pipelines for developments three to ten years out — far enough that they haven’t yet consolidated into products or policy debates, but close enough that their trajectories are somewhat visible. The summit then becomes the public-facing moment where that scanning gets translated into cross-sector conversation.
Whether this produces actionable outcomes is a fair question. The summit format — two days, over a thousand participants, multiple tracks — is designed for exposure and network-building rather than negotiation. What GESDA can plausibly claim is that it creates a standing capacity to notice things early, and a recurring occasion where the people who will eventually need to respond to those things can encounter them before the response is already determined by market dynamics or crisis conditions. For a technology like neurotechnology, where regulatory frameworks barely exist and commercial applications are advancing rapidly, that early encounter may be the point.